TuHURA Biosciences, Inc. (HURA) Stock Analysis & Investment Frameworks
TuHURA Biosciences, Inc. (HURA) stock analysis on Invetso. Review TuHURA Biosciences, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
TuHURA Biosciences, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
TuHURA Biosciences, Inc. Key Financial Metrics
- Market Cap: $109.29M
- Revenue: $N/A
- ROE: -154.32%
- ROIC: -137.40%
- Dividend Yield: N/A
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
TuHURA Biosciences, Inc. Investment Frameworks
Invetso analyzes TuHURA Biosciences, Inc. (HURA) across the following frameworks:
- TuHURA Biosciences, Inc. 10Y Growth Potential
- TuHURA Biosciences, Inc. Scenario Analysis
- TuHURA Biosciences, Inc. Risks & Opportunities
- TuHURA Biosciences, Inc. Economic Moat
- TuHURA Biosciences, Inc. Business Model
- TuHURA Biosciences, Inc. Management
- TuHURA Biosciences, Inc. SWOT Analysis
- TuHURA Biosciences, Inc. Porter's 5 Forces
- TuHURA Biosciences, Inc. PESTLE Analysis
- TuHURA Biosciences, Inc. ESG Analysis